Labetalol S.A.L.F.

Labetalol Hydrochloride, the active ingredient in Labetalol S.A.L.F., is a alpha/beta-adrenergic blocker presented as an injectable solution for intravenous use. It treats hypertension, including hypertensive emergencies, in adult patients.

GNH USA supplies Labetalol S.A.L.F. as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Labetalol is an antihypertensive agent that acts on the cardiovascular system to lower blood pressure.

- Hypertension: provides rapid reduction of elevated blood pressure in chronic hypertension. - Hypertensive emergencies: enables controlled lowering of severe blood pressure spikes in acute settings. - Peri‑operative hypertension: helps manage blood pressure during surgical procedures.

Labetalol may cause a range of adverse reactions, some of which are more frequently observed than others.

Common Side Effects: - Dizziness or light‑headedness. - Headache. - Nausea or vomiting. - Fatigue. - Nasal congestion.

Serious or Rare Side Effects: - Severe hypotension. - Bradycardia or heart block. - Bronchospasm in patients with asthma. - Hepatic dysfunction. - Allergic reactions such as rash or anaphylaxis.

When using Labetalol, several safety considerations should be observed.

- Monitor blood pressure: avoid excessive hypotension. - Assess cardiac function: use cautiously in patients with heart failure or conduction abnormalities. - Check liver function: dose adjustments may be needed in hepatic impairment. - Avoid abrupt discontinuation: sudden withdrawal can precipitate rebound hypertension. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Labetalol can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Other antihypertensives (e.g., ACE inhibitors, diuretics): risk of additive hypotension. - Calcium channel blockers (especially verapamil, diltiazem): may cause severe bradycardia. - Non‑selective beta‑blockers: increased risk of bradycardia and heart block.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: may mask hypoglycaemia symptoms. - Anesthetic agents (e.g., halothane): may enhance cardiovascular depression.